Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Hypoglycemia has been associated with an increased risk of cardiovascular (CV) events and all-cause mortality. This study assessed whether, in a nationally representative population, there is an association between hypoglycemia, the risk of CV events, and all-cause mortality among insulin-treated people with type 1 diabetes or type 2 diabetes. RESEARCH DESIGN AND METHODS: This retrospective cohort study used data from the Clinical Practice Research Datalink database and included all insulin-treated patients (≥30 years of age) with a diagnosis of diabetes. RESULTS: In patients who experienced hypoglycemia, hazard ratios (HRs) for CV events in people with type 1 diabetes were 1.51 (95% CI 0.83, 2.75; P = ns) and 1.61 (1.17, 2.22), respectively, for those with and without a history of CV disease (CVD) before the index date. In people with type 2 diabetes, the HRs for patients with and without a history of CVD were 1.60 (1.21, 2.12) and 1.49 (1.23, 1.82), respectively. For all-cause mortality, HRs in people with type 1 diabetes were 1.98 (1.25, 3.17), and 2.03 (1.66, 2.47), respectively, for those with and without a history of CVD. Among people with type 2 diabetes, HRs were 1.74 (1.39, 2.18) and 2.48 (2.21, 2.79), respectively, for those with and without a history of CVD. The median time (interquartile range) from first hypoglycemia event to first CV event was 1.5 years (0.5, 3.5 years) and 1.5 years (0.5, 3.0 years), respectively, for people with type 1 and type 2 diabetes. CONCLUSIONS: Hypoglycemia is associated with an increased risk of CV events and all-cause mortality in insulin-treated patients with diabetes. The relationship between hypoglycemia and CV outcomes and mortality exists over a long period.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CVD mortality accounts for 30-44% of all deaths in patients with T1DM.[780][781][782][783][784]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [782]
In the citing paper
“People with T1DM face a three-fold increase in mortality compared with the general population”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [782]
In the citing paper
“which translates into an 11-year reduction in life expectancy”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [782]
In the citing paper
“multiple studies have shown a strong relationship between hypoglycemia (severe or not severe) and cardiovascular events and mortality”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [200]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Self-citationIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“Since the ACCORD and VADT results were published, attempts have been made to assess whether a relationship exists between hypoglycemia and CV risk or mortality, but only recently has a consensus begun to emerge suggesting that there is a link between the two (6,8,9).”
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Cited by
Items 301–355 of 355
Munshi, M. N. (2017) · Wiley eBooks · doi:10.1002/9781118954621.ch24 · Cited by 2
Acute Complications of Diabetes
Hirsch, I. B., & Childs, B. P. (2017) · American Diabetes Association eBooks · doi:10.2337/9781580405690.ch09 · Cited by 1
The ups and downs of blood sugar
Morris, D. (2015) · Independent Nurse · doi:10.12968/indn.2015.6.29
Conthe, P., Artola, S., Goday, A., Abad, M., Capel, M., & García-Losa, M. (2015) · PharmacoEconomics Spanish Research Articles · doi:10.1007/s40277-015-0051-5
Diabetes Mellitus: Diagnosis and Care
Giangola, J. (2019) · Organ and tissue transplantation · doi:10.1007/978-3-319-05257-1_2012
Short-term aerobic exercise training in type 2 diabetes
Kearney, M. L. (2015) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/50150
Working with patients to promote self-management
Phillips, A. (2017) · British Journal of Healthcare Management · doi:10.12968/bjhc.2017.23.7.308
Kattan, W. (2017) · STARS (University of Central Florida)
Seufert, J., Galle, J.-C., Manning, M., Schmid, V., & Lehrke, M. (2017) · Diabetologie und Stoffwechsel · doi:10.1055/s-0043-112658
“Insbesondere für hypoglykämische Episoden werden ungünstige Auswirkungen und Zusammenhänge mit kardiovaskulären Risiken diskutiert [45].”
BackgroundRecommandations quant à l’insulinothérapie chez les patients dépendants
Felix, B., FischerTaeschler, D., Keller, U. B., Bulti, U. L., Meichtry, B., & Willi, C. (2016) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2016.02558
Obesity, Diabetes and Cardiovascular Diseases
Qureshi, A. S. (2018) · Journal of Human Anatomy · doi:10.23880/jhua-16000127
Montvida, O. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.122920
Risk Indicators of Non-severe Hypoglycemia in Type 2 Diabetes: An Analysis of Real World Data
Au, N. H. (2018) · Scholarship@Western (Western University)
Problem solving in type 1 diabetes for primary care nurses–part 2
Morris, D. (2019) · Independent Nurse · doi:10.12968/indn.2019.12.25
Mesa 1: Diabetes mellitus tipo 1 y enfermedad cardiovascular
González, L., Chertkoff, A., Burgos, M. A., Trifone, L., Sanabria, H. D., Koleff, C. K., Roccatagliata, L. E., Rama, V., Pomares, M. L., Suppo, M., et al. (2020) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v54i2sup.251 · Cited by 1
Winocour, P. H., Moore-Haines, K., Sullivan, K. R., Currie, A., Solomon, A., & Hardy, D. (2020) · British Journal of Diabetes · doi:10.15277/bjd.2020.252
Noh, R. M., Graveling, A. J., Lang, N. N., White, A. C., Lee, K. K., Mills, N. L., Newby, D. E., Lang, C. C., & Frier, B. M. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.258
Improving outcomes for older people with diabetes
Morris, D. (2021) · Practice Nursing · doi:10.12968/pnur.2021.32.7.270
Diabetes Management in the Elderly Patient with Kidney Disease
Molitch, M. E. (2015) · Cited by 2
Lezhenko, G. O., Pashkovа, O. Y., & Самойлик, К. В. (2021) · Pathologia · doi:10.14739/2310-1237.2021.2.217936
“Diabetes appears as a separate and independent risk factor for fatal and nonfatal cardiovascular disorders [7].”
BackgroundType 2 diabetes: glycaemic control
FRCP, D. L. M. (2017) · Wiley eBooks · doi:10.1002/9781119052210.ch10
Noh, R. M., Graveling, A. J., Lang, N. N., White, A., Lee, K. K., Mills, N. L., Newby, D. E., Lang, C. C., & Frier, B. M. (2020) · doi:10.21203/rs.3.rs-123770/v1
Pashkova, E. Y. (2022) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2022-11-1-65-72
Ling, S., Zaccardi, F., Lawson, C. A., Seidu, S., Davies, M. J., & Khunti, K. (2021) · doi:10.2337/figshare.13568543.v1
“8 Mediation analysis: hypoglycemia and mortality Hypoglycemia has been suggested as a possible mechanism linking intensive glucose control and risk of death in patients with T2D.”
Self-citationLing, S., Zaccardi, F., Lawson, C. A., Seidu, S., Davies, M. J., & Khunti, K. K. (2021) · doi:10.2337/figshare.13568543
Self-citationNetwork analysis of depressive and anxiety symptoms in older Chinese adults with diabetes mellitusPreprint
Guo, Z., Cui, Y., Li, Y., Lü, H., Liu, Q.-H., & Zhu, X. (2023) · Research Square · doi:10.21203/rs.3.rs-2712115/v1
Perioperatives Management bei alten Menschen mit Diabetes mellitus
Lee-Barkey, Y., & Stratmann, B. (2023) · Die Diabetologie · doi:10.1007/s11428-023-01093-6
“Fehlerhafte Insulindosierungen mit schweren Hypoglykämien können zu Komplikationen mit Todesfolge führen [35].”
BackgroundBasics and applications of continuous glucose monitoring (CGM)
(2024) · International Research Journal of Modernization in Engineering Technology and Science · doi:10.56726/irjmets49403
The role of m6A modification in cardiovascular disease: A systematic review and integrative analysis
Feng, X.-M., Zhang, Y., Chen, N., Ma, L.-L., Gong, M., & Yan, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113603
SGLT2 Inhibitors and Mechanism of Cardiovascular Benefits in Type 2 Diabetes
Nandave, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-7568-2_2 · Cited by 1
Guerra, C., Corréard, F., Montégut, C., Nakache, J., Mascio, T. D., Villani, P., Honoré, S., Daumas, A., Couderc, A., & Bérard, C. (2024) · Research Square · doi:10.21203/rs.3.rs-5349587/v1
Emotional Distress and Cardiovascular Health in Young Adults with Type 1 Diabetes
Armentrout, B. L., Ahmed, B. H., Waraphok, S., Huynh, J., & Griggs, S. A. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11120391 · Cited by 2
Closed-loop Versus Sensor Pumps Therapy for Type 1 Diabetes: A Systematic Review and Meta-analysis
Alamoudi, H., Alzaydani, A. I., Alghamdi, H. A., Alqahtani, N. A., Alshuhayeb, A. A., Almutairi, R. S., & Alhodibi, M. H. (2024) · Journal of Advanced Trends in Medical Research · doi:10.4103/atmr.atmr_222_24
Metabolic Associations between Cardiovascular Disease, Diabetes and Kidney Disease
王, 佳. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.152491
Razdan, O., Mani, N., Soni, J., Patel, A., Chilamakuri, D., Rajput, N., & Shah, D. (2025) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_859_25
Kugathasan, L., Ragi, N., Debnath, S., Sridhar, V. S., Maity, S., Feng, T., Treviño, E., Perkins, B. A., Cherney, D. Z. I., & Sharma, K. (2025) · Physiological Reports · doi:10.14814/phy2.70465 · Cited by 3
“Considering the substantial residual risk for cardiovascular disease and kidney failure in individuals with T1D despite guideline-directed therapy (Khunti et al., 2015; Lee et al., 2019), the use of SGLT2 inhibitors may improve the overall benefit–risk balance in patients with T1D.”
Tabassum, M., Tabassum, M., Islam, M. A., Dutta, M., Rahman, M. M., Ghosh, P., & Ashrafuzzaman, S. (2025) · Bangladesh Journal of Endocrinology and Metabolism · doi:10.4103/bjem.bjem_14_25
King, D., Akbari, A., Gravenor, M. B., Lawrence, M., Weston, C. F. M., Rice, S., Hopkins, C., Phillips, L., Halcox, J., & Harris, D. E. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf158
“12 Overall, there was a fall in the mean age of diagnosis of DM.”
Camoin, M., Velho, G., Saulnier, P.-J., Potier, L., Abouleka, Y., Carpentier, C., Dubois, S. G., Larroumet, A., Rigalleau, V., Gand, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19736409
González‐Vidal, T., Lambert, C., García, A. V., Villa-Fernández, E., Pujante, P., Ares, J., Torre, E. L. M., & Delgado, E. (2024) · Figshare · doi:10.6084/m9.figshare.25572601
Insulin in Its Second Century: History, Evolution, and Aspirations
Mayer, J. P., Thalluri, K., Mickelson, E., Stowell, M. H. B., & DiMarchi, R. D. (2025) · Wiley eBooks · doi:10.1002/9781119824701.ch08
Qi, X., Xu, J., Chen, G., Liu, H., Liu, J., Wang, J., Zhang, X., Hao, Y., Wu, Q., & Jiao, M. (2021) · Figshare · doi:10.6084/m9.figshare.17004342
Camoin, M., Velho, G., Saulnier, P.-J., Potier, L., Abouleka, Y., Carpentier, C., Dubois, S. G., Larroumet, A., Rigalleau, V., Gand, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19736406
Camoin, M., Velho, G., Saulnier, P.-J., Potier, L., Abouleka, Y., Carpentier, C., Dubois, S. G., Larroumet, A., Rigalleau, V., Gand, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19736400
Camoin, M., Velho, G., Saulnier, P.-J., Potier, L., Abouleka, Y., Carpentier, C., Dubois, S. G., Larroumet, A., Rigalleau, V., Gand, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19736403
Feng, J., & Yang, J. (2026) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2026.102227
Bilal, A., Horton, W. B., Kovatchev, B. P., Casu, A., Pratley, R., Kanapka, L., & Beck, R. W. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261432166
Caution Before Routine Preoperative Hemoglobin A 1c Testing
Hermanides, J., Hulst, A. H., & van Zuylen, M. L. (2026) · JAMA Surgery · doi:10.1001/jamasurg.2026.0478
Li, M., Liu, J., Sun, P., Zhao, X., Fan, C., Guo, X., Zhao, W., & Guo, X. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1896142 · Cited by 2
“Observational evidence indicates that hypoglycemia is associated with higher risks of cardiovascular events and death in individuals with diabetes (8), and severe episodes impose additional psychosocial harms, including fear of hypoglycemia and impaired quality of life (9).”
Kageyama, M., Horii, T., Oikawa, Y., & Mihara, K. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113539
Sherratt-Mayhew, S., Buchipudi, A., Page, C., Yee, A. L. J., Persad, K., Khatoon, A., Idrissi, M., Rakkar, A., OSMAN, S. A., Waheed, S., et al. (2026) · Frontiers in Health Services · doi:10.3389/frhs.2026.1862035
“Severe hypoglycaemia — defined as any instance of low blood glucose that results in marked cognitive impairment requiring external assistance for recovery — is associated with increased morbidity, mortality and healthcare resource utilisation (2 – 4).”
Continuous Glucose Monitoring Glucometrics and Their Role in Predicting Diabetes Complications
Schweiger, D. Š., Mozzillo, E., & Battelino, T. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2026.08.019
(2026) · ADA Clinical Compendia · doi:10.2337/db20261-33
Metadata
- Authors
- Khunti, K., Davies, M., Majeed, A., Thorsted, B. L., Wolden, M. L., & Paul, S. K.
- Affiliations
- University of Leicester (GB)
- Imperial College London (GB)
- Novo Nordisk (Denmark) (DK)
- QIMR Berghofer Medical Research Institute (AU)
- Corresponding author
- Khunti, Kamlesh
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-12-09
- Volume
- 38
- Issue
- 2
- Pages
- 316-322
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2128592897
- Cited by
- 356
- References
- 32
- Citations by year
- 2026: 13 · 2025: 23 · 2024: 26 · 2023: 34 · 2022: 26 · 2021: 39 · 2020: 33 · 2019: 38 · 2018: 27 · 2017: 38 · 2016: 39 · 2015: 20
- FWCI
- 25.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hypoglycemia, cardiovascular disease, all-cause mortality, type 1 diabetes, type 2 diabetes, insulin-treated diabetes, cardiovascular events, mortality risk
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Angiopathies, England, Epidemiologic Methods, Female, Humans, Hypoglycemia, Hypoglycemic Agents, Male, Middle Aged, Insulins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.